Adriano De Santis | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection	JOURNAL OF HEPATOLOGY	2017
The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY	2017
Nutritional habits in patients with chronic liver disease: adherence of real life diet to international guidelines and its association with disease stage	JOURNAL OF HEPATOLOGY	2017
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption	JOURNAL OF HEPATOLOGY	2017
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2016
Management of refractory typical GERD symptoms	NATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY	2016
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors	DIGESTIVE AND LIVER DISEASE	2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia	HEPATOLOGY	2016
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement	AUTOIMMUNITY REVIEWS	2016
Gut Microbiota and Alcoholic Liver Disease	REVIEWS ON RECENT CLINICAL TRIALS	2016
TIPS and HCC: friends or foes ?	JOURNAL OF IMAGING AND INTERVENTIONAL RADIOLOGY	2016
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.	HEPATOLOGY	2015
The human gut microbiota and virome: potential therapeutic implications	DIGESTIVE AND LIVER DISEASE	2015

Progetti di Ricerca

ROLE OF CIRCULATING TUMOR CELLS (CTC) IN THE PREDICTION OF SURVIVAL AND RESPONSE TO TREATMENT IN PATIENTS WITH INTERMEDIATE AND ADVANCED HEPATOCELLULAR CARCINOMA (HCC).